Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01875185 · ClinicalTrials.gov registry record · Phase 4

Hormones Inflammation and Thrombosis

A Phase 4 study, sponsored by Johns Hopkins University.

Terminated
Registry status
Phase 4
Development phase
100
Enrollment target

NCT01875185: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.

NCT01875185 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01875185, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The investigators are attempting to determine if the response to aspirin in women is related to the level of estrogen and progesterone that a woman has.

Primary Outcome

Urinary thromboxane (pg/mg creatinine) will be measured in premenopausal and postmenopausal women at baseline and then after taking on aspirin for 7 days.

Interventions

  • DRUG Aspirin 81 mg

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-12
Est. Completion 2013-11
Phase Phase 4
Johns Hopkins University

1,448 total trials

Why NCT01875185 stopped before completion

NCT01875185 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Aspirin 81 mg is the first listed.

NCT01875185 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01875185 about?

NCT01875185 is a clinical study titled "Hormones Inflammation and Thrombosis". The investigators are attempting to determine if the response to aspirin in women is related to the level of estrogen and progesterone that a woman has.

What is the current status of trial NCT01875185?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2012-12. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01875185?

The interventions under investigation include: Aspirin 81 mg (DRUG).

Who is sponsoring clinical trial NCT01875185?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01875185's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01875185, the US trial registry maintained by the National Library of Medicine. NCT01875185 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.